-
-
-
-
-
-
-
Bausch Health Co. Inc. (BHC) Misses Q4 EPS by 151c; offers guidance
-
-
-
-
-
-
-
Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
-
-
-
-
-
-
-
Bausch Health Co. Inc. (BHC) Misses Q3 EPS by 56c
-
-
-
-
-
-
-
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
-
-
-
-
-
-
-
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
-
-
-
-
-
-
-
Bausch Health to reduce debt by $900 million using cash on hand
-
-
-
-
-
-
-
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two
-
446,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

